Today: 7 February 2026
Subscribe
Browse Category

NYSE:KMB News 14 January 2026 - 7 February 2026

Kenvue stock price holds near $18 as Kimberly-Clark deal math tightens — what to watch next week

Kenvue stock price holds near $18 as Kimberly-Clark deal math tightens — what to watch next week

Kenvue shares closed Friday at $18.13, up 0.33%, with about 63.5 million shares traded. The Kimberly-Clark offer values Kenvue at roughly $18.76 per share, leaving a deal spread of about 3%. Both companies’ shareholders approved the merger, which is expected to close in the second half of 2026 pending regulatory approvals. Kenvue’s dividend record date is Feb. 11, with earnings due Feb. 17.
7 February 2026
··
Kenvue stock price today: KVUE inches up as Feb. 17 results near and Kimberly-Clark deal math grips shares

Kenvue stock price today: KVUE inches up as Feb. 17 results near and Kimberly-Clark deal math grips shares

Kenvue shares rose 0.2% to $18.11 Friday afternoon, trading about 3.6% below Kimberly-Clark’s $18.79-per-share offer. Kenvue will report Q4 and full-year results on Feb. 17 but will skip its usual conference call as the merger process continues. Shareholders of both companies approved the deal on Jan. 29; regulatory clearance remains pending.
6 February 2026
···
Kenvue stock price today: KVUE ticks up premarket as Feb. 17 results near, earnings call scrapped

Kenvue stock price today: KVUE ticks up premarket as Feb. 17 results near, earnings call scrapped

Kenvue shares rose 0.2% premarket Friday after the company set Feb. 17 for its earnings release and said it will not hold a quarterly call due to its pending deal with Kimberly-Clark. Each Kenvue share will convert into 0.14625 Kimberly-Clark shares plus $3.50 cash if the merger closes, leaving Kenvue stock about 70 cents below the implied value. Investors remain focused on deal timing and ongoing product litigation.
6 February 2026
···
Procter & Gamble stock rises as Wall Street turns defensive — what traders watch next

Procter & Gamble stock rises as Wall Street turns defensive — what traders watch next

Procter & Gamble shares rose 1.1% to $151.58 Friday afternoon as investors moved into consumer-staples stocks amid inflation concerns and policy uncertainty. The S&P 500 fell 0.4% while the XLP staples ETF gained 1.2%. Senate obstacles raised the risk of a partial U.S. government shutdown before the midnight funding deadline. Investors await the Feb. 6 jobs report and further policy signals.
30 January 2026
····
Kenvue stock price dips as KVUE dividend set and Kimberly-Clark vote nears

Kenvue stock price dips as KVUE dividend set and Kimberly-Clark vote nears

Kenvue shares fell 0.3% to $17.44 Wednesday as investors awaited a Jan. 29 shareholder vote on Kimberly-Clark’s takeover bid. Kenvue declared a $0.2075 quarterly dividend, payable Feb. 25. The merger would give Kenvue holders 0.14625 Kimberly-Clark shares plus $3.50 cash per share. Kenvue and its board face shareholder lawsuits seeking more merger disclosures.
28 January 2026
···
Kenvue stock edges higher as Kimberly-Clark profit beat puts takeover vote back in play

Kenvue stock edges higher as Kimberly-Clark profit beat puts takeover vote back in play

Kenvue shares rose 0.2% after Kimberly-Clark reported strong quarterly results and reaffirmed its $40 billion bid. Shareholders vote on the deal Jan. 29, with Kenvue holders set to receive $3.50 in cash and 0.14625 Kimberly-Clark shares per Kenvue share. Both companies confirmed financing plans. Deal risk persists due to Kenvue’s ongoing lawsuits and regulatory scrutiny.
27 January 2026
··
Kenvue stock steadies near $18 as investors eye Jan. 29 merger vote — here’s what matters next week

Kenvue stock steadies near $18 as investors eye Jan. 29 merger vote — here’s what matters next week

Kenvue closed Friday at $17.80, up 0.3%, ahead of a merger vote with Kimberly-Clark set for Jan. 29. The deal values Kenvue shares at about $18.45, but ongoing shareholder lawsuits and unresolved litigation over Kenvue brands threaten delays. Proxy advisers back the deal despite legal risks. Both companies hold shareholder meetings Monday to decide the merger’s fate.
25 January 2026
··
Kenvue (KVUE) stock price barely budges as Kimberly-Clark deal vote nears

Kenvue (KVUE) stock price barely budges as Kimberly-Clark deal vote nears

Kenvue shares rose 0.1% to $17.77 Friday as investors await a Jan. 29 shareholder vote on its proposed sale to Kimberly-Clark. The deal would give Kenvue holders $3.50 in cash and 0.14625 Kimberly-Clark shares per Kenvue share. Institutional Shareholder Services recommended approval but cited litigation risks. Trading volume has surged ahead of the vote.
23 January 2026
···
Kenvue stock ticks up as investors size up Kimberly-Clark takeover vote in days

Kenvue stock ticks up as investors size up Kimberly-Clark takeover vote in days

Kenvue shares rose 0.6% to $17.31 in late-morning New York trading Tuesday as investors awaited a Jan. 29 shareholder vote on its proposed sale to Kimberly-Clark. The deal’s outcome remains uncertain amid ongoing litigation risks tied to Kenvue’s legacy products. ISS has backed the merger but flagged legal concerns. Kenvue’s virtual shareholder meeting is scheduled for 9:00 a.m. Eastern on Jan. 29.
20 January 2026
··
Johnson & Johnson stock heads into earnings after a mild dip — what could move JNJ next

Johnson & Johnson stock heads into earnings after a mild dip — what could move JNJ next

Johnson & Johnson shares closed down 0.4% at $218.66 Friday ahead of the Martin Luther King Jr. Day market holiday. The S&P 500 health care sector fell 0.8%. J&J reports fourth-quarter results Wednesday, Jan. 21, with investors focused on earnings and 2026 guidance. The NYSE will reopen Tuesday after the holiday.
18 January 2026
·······
Kenvue stock has a new catalyst: ISS backs Kimberly-Clark merger ahead of Jan. 29 vote

Kenvue stock has a new catalyst: ISS backs Kimberly-Clark merger ahead of Jan. 29 vote

Kenvue shares closed at $17.20 Friday, down 0.35%, ahead of a Jan. 29 shareholder vote on its sale to Kimberly-Clark. Proxy adviser ISS recommended investors back the deal but cited ongoing legal and market risks. Kenvue updated merger disclosures after lawsuits challenged the process. The offer values Kenvue at about $18.03 per share, a 4.6% premium to Friday’s close.
18 January 2026
··
Kenvue stock edges up as Kimberly-Clark vote nears — the deal spread traders are watching

Kenvue stock edges up as Kimberly-Clark vote nears — the deal spread traders are watching

Kenvue shares rose 0.4% to $17.08 in mid-morning trading after Kimberly-Clark filed new deal documents with U.S. regulators. The stock remains about 5% below the value implied by the pending cash-and-stock takeover. Kenvue shareholders are set to vote on the deal Jan. 29. The transaction’s value fluctuates with Kimberly-Clark’s share price.
14 January 2026
···
1 2

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Go toTop